curasan AG received licence for ATR®

Kleinostheim, Germany, 16 October 2009 – curasan AG, which is listed on the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has been received CE certification and, therefore, marketing authorization for the ATR® (Advanced Tissue Regeneration) product.

ATR® is a disposable system that is used to enrich the body’s own growth factors to a level many times higher than normal blood values. The most important areas of application are serious skin damage, such as decubitus and ulcers, large area burns, skin transplants, plastic surgery and the optimised regeneration of bone and mucous tissue.


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button